suxametonium clorura aguettant 10 mg/ml
laboratoire aguettant - franta - suxamethonii chloridum - sol. inj. in seringa preumpluta - 10mg/ml - miorelaxante periferice derivati de colina
tusocalm 7,5mg/120mg
arena group s.a. - romania - combinatii - compr. - 7,5mg/120mg - antitusive, excl.combinatii cu expectorante alcaloizi din opiu si derivati
cereton 250 mg/ml soluţie injectabilă
farmfirma sotex saÎ - cholini alfosceras - soluţie injectabilă - 250 mg/ml
pylclari
curium pet france - piflufolastat (18f) - prostate neoplasme - produse radiofarmaceutice de diagnosticare - acest medicament este destinat exclusiv diagnosticului. pylclari is indicated for the detection of prostate-specific membrane antigen (psma) positive lesions with positron emission tomography (pet) in adults with prostate cancer (pca) in the following clinical settings:primary staging of patients with high-risk pca prior to initial curative therapy,to localize recurrence of pca in patients with a suspected recurrence based on increasing serum prostate-specific antigen (psa) levels after primary treatment with curative intent. pylclari is indicated for use with positron emission tomography (pet).
certican 0,25 mg
novartis pharma gmbh - germania - everolimus - compr. pt. disp. orala - 0,25mg - imunosupresoare imunosupresoare selective
certican 0,1 mg
novartis pharma gmbh - germania - everolimus - compr. pt. disp. orala - 0,1mg - imunosupresoare imunosupresoare selective
everolimus sandoz 0,25 mg
novartis pharma gmbh - germania - everolimus - compr. - 0,25mg - imunosupresoare imunosupresoare selective
everolimus sandoz 0,5 mg
novartis pharma gmbh - germania - everolimus - compr. - 0,5mg - imunosupresoare imunosupresoare selective
everolimus sandoz 0,75 mg
novartis pharma gmbh - germania - everolimus - compr. - 0,75mg - imunosupresoare imunosupresoare selective
acard 75 mg comprimate gastrorezistente
pharmaceutical works polpharma s.a. - acid acetylsalicylicum - comprimate gastrorezistente - 75 mg